Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Acquires Fluo3 and Fluo4 Probe Lines from TEF Labs

NEW YORK (GenomeWeb News) - Invitrogen said yesterday that it has purchased two molecular probe product lines from TEF Labs.
The purchase gives Invitrogen TEF Labs' fluo3 and fluo4 product lines and all related intellectual property. Invitrogen's Molecular Probes business will assume the manufacture and sale of fluo 3 and fluo 4.
TEF Labs divested the product lines in order to "focus our resources on the development of new products and technologies," said Akwasi Minta, CEO of TEF Labs, in a statement.
Financial details were not disclosed.
The acquisition is Invitrogen's second announced this month. On Sept. 1, the company said that it plans to acquire 

cell-based assay company Sentigen Holding for around $25.9 million in cash

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.